| |
This journal aims to provide a forum for publication
of clinical and experimental pharmacology studies related to diabetes,
obesity and metabolism, including evaluations of new glucose and
weight-lowering drugs, new therapeutic developments in the management
and prevention of diabetic complications, e.g. growth factors
and biotechnology products for foot ulcers, and clinical trials
involving established medicines, e.g. optimal treatment of hypertension,
lipids or infection in the diabetic population.
The journal invites brief review articles relevant
to practising clinicians, original articles under separate sections
of clinical and basic science, and provides a forum to publish
hypotheses and letters to the editor on drug and therapeutic issues
related to any aspect of diabetes, obesity and metabolism.
|
